Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
16.4
26.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Henan Lingrui Pharmaceutical Co Ltd
Henan Lingrui Pharmaceutical Co Ltd
Minority Interest
Henan Lingrui Pharmaceutical Co Ltd
Minority Interest Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
|
Minority Interest
¥7.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Minority Interest
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Minority Interest
¥575.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Minority Interest
¥564.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
41%
|
CAGR 10-Years
5%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Minority Interest
¥20.9m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-16%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Henan Lingrui Pharmaceutical Co Ltd
Glance View
Henan Lingrui Pharmaceutical Co., Ltd. engages in the production and sale of medicine and health products. The company is headquartered in Xinyang, Henan and currently employs 2,500 full-time employees. The company went IPO on 2000-10-18. The firm's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The firm distributes its products throughout China, with Henan Province and Beijing as its major markets.
See Also
What is Henan Lingrui Pharmaceutical Co Ltd's Minority Interest?
Minority Interest
7.8m
CNY
Based on the financial report for Sep 30, 2024, Henan Lingrui Pharmaceutical Co Ltd's Minority Interest amounts to 7.8m CNY.
What is Henan Lingrui Pharmaceutical Co Ltd's Minority Interest growth rate?
Minority Interest CAGR 10Y
-8%
Over the last year, the Minority Interest growth was 2%. The average annual Minority Interest growth rates for Henan Lingrui Pharmaceutical Co Ltd have been 1% over the past three years , -6% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
